New Shortage Notification Rules Bear Fruit In Australia
Moves Afoot To Better Anticipate Supply Problems
The introduction of mandatory reporting of medicine shortages in Australia has caused a sharp increase in the number of notifications. Most of them related to manufacturing problems, although commercial issues and changes in demand patterns also played a part.
You may also be interested in...
Drug sponsors will face penalties in Australia if they fail to comply with new rules on the mandatory reporting of medicines shortages that come into effect at the beginning of 2019 to replace the current "ineffective" voluntary system.
Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.
A “powerful new vision” for the post-Brexit UK regulatory framework was unveiled at a conference organized by the BioIndustry Association and the medicines regulator, the MHRA.